Ovarian Cancer Screening Study

When treated in the earliest stages, the five-year survival rate for ovarian cancer is over 90%. If found and treated in the later stages, the survival rate can be as low as 18%. Unfortunately, only 15% of cases are found in the early stage due to ovarian cancer’s non-specific symptoms and lack of early detection tests.

Atlantic Health is evaluating periodic blood tests that may be helpful in early detection of ovarian cancer.

The Ovarian Cancer Screening Study (CA 125 Algorithm) is available for women 50-74 years old who:

• Are post-menopausal (no period for one year or longer)
• No cancer treatment in the past 12 months (speak with study coordinator for exceptions)
• Have at least one ovary
• Have a health care provider who provides your yearly wellness exam

• Telephone interview
• Blood test (once a year or more often, if indicated)
• Medical history questionnaire and surveys
• Transvaginal ultrasound (for some participants)

• Receive possible ovarian cancer screening test at no cost
• Contribute valuable information to medical research

Research studies, also known as clinical trials, are the most effective tools for evaluating new ways to prevent and treat cancer. Many people with cancer are living longer and enjoying a better quality of life because of research studies. By participating in cancer research, you advance medical science and help others who will need cancer treatment in the future.